2018-2023 Global Cardiac Rhythm Management (CRM) Devices Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cardiac Rhythm Management (CRM) Devices market for 2018-2023.
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
Increasing instances of heart failure and other cardiac disorders and rising sedentary lifestyle among the population are estimated to boost market growth through 2025.
The classification of Cardiac Rhythm Management Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2017 is about 49.1%. The ICD in 2017 is about 36.6%.
Cardiac Rhythm Management Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2017 is 42.8%. And the market share used bradycardia in 2018 is 39.9%.
North America region is the largest supplier of Cardiac Rhythm Management Device, with a production market share nearly 84.7% in 2017. Europe is the second largest supplier of Cardiac Rhythm Management Device Media, enjoying production market share nearly 12.4% in 2017.
North America is the largest consumption place, with a consumption market share nearly 51.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.3%, Cardiac Rhythm Management Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Market competition is intense among top 5. Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, LivaNova (Sorin) are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Cardiac Rhythm Management (CRM) Devices will register a 4.6% CAGR in terms of revenue, reach US$ 13400 million by 2023, from US$ 10200 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Rhythm Management (CRM) Devices market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Segmentation by application:
This report also splits the market by region:
Middle East & Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
St. Jude Medical (Abbott)
Lepu (Qinming Medical)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Cardiac Rhythm Management (CRM) Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Cardiac Rhythm Management (CRM) Devices market by identifying its various subsegments.
Focuses on the key global Cardiac Rhythm Management (CRM) Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cardiac Rhythm Management (CRM) Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cardiac Rhythm Management (CRM) Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.